跳至主要内容
临床试验/NL-OMON47403
NL-OMON47403招募中不适用

Isolation, immortalization and characterization of human B lymphocytes for the development of diagnostic and therapeutic antibodies against cancer. - Human antibodies against cancer.

AIMM Therapeutics BV0 个研究点目标入组 75 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • o patients with a hematologic malignancy (leukemia or lymphoma) who received a hematopoetic stem cell transplantation and subsequently developed graft-versus-host disease and/or a sustained graft-versus-leukemia response;
  • o patients with melanoma who showed spontaneous or treatment induced tumor regression, preferably in the presence of signs of auto-immunity , like vitiligo;
  • o patients with gastrointestinal tumors (pancreatic or oesophagus) with either tumor regression or slower then expected tumor growth.

排除标准

  • 未提供

研究者

相似试验